Molbio Diagnostics informs about SAST
Date: 24-09-2026Molbio Diagnostics has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for India Business Excellence Fund III.
The above information is a part of company’s filings submitted to BSE.